Johnson & Johnson Procept Bio Robotics Corp Transaction History
Johnson & Johnson
- $314 Million
- Q3 2024
A detailed history of Johnson & Johnson transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Johnson & Johnson holds 357,939 shares of PRCT stock, worth $23.7 Million. This represents 9.14% of its overall portfolio holdings.
Number of Shares
357,939
Previous 357,939
-0.0%
Holding current value
$23.7 Million
Previous $21.9 Million
31.14%
% of portfolio
9.14%
Previous 7.55%
Shares
3 transactions
Others Institutions Holding PRCT
# of Institutions
289Shares Held
40.8MCall Options Held
262KPut Options Held
232K-
Vanguard Group Inc Valley Forge, PA5.14MShares$340 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$231 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$116 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA1.49MShares$98.7 Million0.02% of portfolio
-
Loomis Sayles & CO L P1.21MShares$79.9 Million0.12% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.95B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...